Locally delivered plasmin: why should it be superior to plasminogen activators for direct thrombolysis?
- 1 February 2004
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 25 (2), 72-75
- https://doi.org/10.1016/j.tips.2003.12.009
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Alfimeprase: Pharmacology of a Novel Fibrinolytic Metalloproteinase for ThrombolysisPathophysiology of Haemostasis and Thrombosis, 2001
- Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activatorThe American Journal of Cardiology, 2000
- Fibrinolysis with Des-Kringle Derivatives of Plasmin and Its Modulation by Plasma Protease InhibitorsBiochemistry, 1998
- The Hematocrit of the Lung in ManScandinavian Journal of Clinical and Laboratory Investigation, 1966
- Treatment of cerebrovascular thrombosis with fibrinolysin preliminary report∗The American Journal of Cardiology, 1960
- Treatment of thrombophlebitis with a fibrinolytic agentThe American Journal of Cardiology, 1960
- Review of clinical experience with clot-lysing agentsThe American Journal of Cardiology, 1960
- Clinical pharmacology of various types of fibrinolytic enzyme preparationsThe American Journal of Cardiology, 1960
- Effects of Intravenous Administration of Fibrinolysin (Plasmin) in ManCirculation, 1959
- CLINICAL AND EXPERIMENTAL STUDIES ON FIBRINOLYTIC ENZYMESAnnals of the New York Academy of Sciences, 1957